What a remarkable exchange. The head of ABIM criticizing physicians for taking up hobbies, implying that time away from work is for doing MOC.
ABIM seems stunningly out of touch.
This Tue AM, I host the epic discussion btw
@AaronGoodman33
and
@RichardBaron17
on the MOC of the ABIM exclusively on
#HealthcareUnfiltered
podcast.
This is a clip from the pod that U will NOT want to miss. It all started with a petition, now with >11k signatures. watch it all
Happy Father’s Day to my Dad, who came to the US with $12 and worked hard to put two kids through college and med school. Thanks for being a role model!
@PrakritiGaba
Please protect yourself as much as you can. We are all praying for you and your colleagues who are on the front lines, and for your patients.
The
@ABIMFoundation
now lists those who have paid for, taken, & passed the certification exam as "not certified" if they don't pay the MOC fee(s).
Anyone find this defensible?
I've said it before but I'll say it again - if you are looking for step-by-step video instructions on interventional techniques, there is no better resource than the YouTube channel run by
@esbrilakis
RIP William C. Roberts MD - former Editor-in-Chief of The American Journal of Cardiology.
Receiving his hand written critiques of the manuscript in the mail was a distinct honor.
I've held on to the ones he sent.
@mmamas1973
@CMichaelGibson
Sweden's Princess Sofia has announced she is reducing her Royal duties so that she can volunteer at a local hospital.
She has already completed intensive training to prepare for it.
In her new role, she will be disinfecting, cleaning, and working in the kitchen.
Terrible take.
No control group, no detail on how patients were selected, some pts lost to f/u.
We all want a therapy to work, but interpretations like this potentially affect equipoise and hinder enrollment into an ongoing randomized trial.
Observational data that is consistent w/our biases: “definitive real world data!”
Observational data that goes against our biases: “fatally confounded!”
I find this to be really unfortunate phrasing. Trials are hard to do. You can critique the trial but “destroying” years of scientific work is unnecessarily adversarial.
And please don’t respond with unfounded accusations of “corruption” or “lies.” You’ll get blocked.
My attempt to "work from home"
7:30 - enter login on work laptop
7:45 - let dogs out
8:00 - logged in; let dogs in
8-9 - email
9:00 - let dogs out
9-9:15 - start editing paper
9:15 - let dogs in
9:15-10:15 - more email
10:15 - let dogs out
10:17 - let dogs in
10:30 - go to work
The
@vadurham
has been very proactive in preparing for coronavirus. Started 2 weeks ago planning for converting in-person visits to video telemedicine visits, implemented screening of all persons entering the hospital, & encouraged telework for employees. I'm proud to work there.
@DrJMarine
Your assessment of him is totally biased and unfair. He’s done a tremendous amount of good for the US including his work on HIV/AIDS, Ebola, and other serious diseases.
FLAVOUR Trial published in
@NEJM
FFR vs. IVUS to guide PCI.
Trial designed to test non inferiority of FFR with 24-month death/MI/revasc as the endpoint.
Event rates: 8.1% FFR vs. 8.5% IVUS, p=0.01 for noninferiority
For anyone who is submitting a grant or has submitted a grant, remember that even great ideas get rejected. It takes persistence to get funded.
High marks for concise language, a clear plan, & data sharing in this application.
PI appears to be inexperienced.
@HannaSorensen
My advice: don't get hung up on academic brand names. As long as you're getting the resources and support you need where you are, you'll be successful.
There is a lot of great research and clinical care going on at places that don't have the powerhouse academic brand.
Truth.
My approach to responding to reviews:
1. Yell profanities at the computer screen
2. Contemplate how my career is over
3. Don’t look at review for 2 days
4. Do the work needed to respond & make paper better
@bnallamo
@rwyeh
@ADAlthousePhD
@CMichaelGibson
Today a manuscript I really care about was accepted for publication. In the 3 years since we finished writing it, it was rejected at 7+ journals. But we believed in the paper’s contribution and know it’s going to impact the field.
Just a reminder not to give up on your work!
Physiology for intermediate left main disease. Interesting study examining deferral vs. revasc for LM with iFR ≤ 0.89.
Revasc associated with improved outcomes compared with deferral
Really excited to attend
@SCAI
in Phoenix next week! Fantastic sessions on coronary, peripheral, &structural along with innovative live cases.
My term as President comes to a close and we will review all the great work we’ve done this year.
Hope to see you there!
Register now for interventional cardiology’s leading conference,
#SCAI2023
:
✅ Learn about the latest scientific updates, innovations, and techniques
✅ Get your hands on new devices
✅ Participate in live cases
✅ Build your network
Register now ➡️
What is the uptake of intra-coronary imaging is in contemporary clinical practice in the US?
@DukeCardiology
@DukeHeartCenter
fellow Zach Wegermann examined this in the
@ACCinTouch
NCDR CathPCI registry in a poster
#TCT2021
Rates are increasing, but are extremely low.
LCx CTO with distal cap at a bifurcation. 7.5F sheathless right
#RadialFirst
Eaucath. Pilot 200 went into continuation. TwinPass + 3g Miracle into OM. Balloon + IVUS + stent + re-IVUS + post dilate. Final result looks good.
$90 for a vial of heparin, $92 for a ticagrelor tablet, aspirin at $1 a piece, $916 for a diagnostic Tiger catheter, $19708 for each Synergy DES. Hospitals charge this much because...they can?
Breakthroughs are important, but in US we have a side effect of heart attacks almost unknown in Europe. Financial toxicity. Something we need to fix. In
@JAMACardio
we detailed out of pocket costs that many people bear.
#ESCCongress
Rounding at the
@vadurham
today.
Saw this in a progress note:
“…pt has been refusing dialysis because he didn’t want to be a burden to his family however his hospital roommate convinced him to consider a trial of HD.”
Veterans are awesome.
#onlyattheVA
One of the biggest challenges to clinical research is private insurance companies not paying any costs for patients enrolled in a clinical trial, even if the randomization is to two different standards of care.
@HeartBobH
@DLBHATTMD
@Drroxmehran
Happy new year everyone!
I ended 2021 with a rapid weight loss and intense ab workout program called …. Gastroenteritis.
Highly effective. Would not recommend.